Literature DB >> 1346799

The purine analogs--a therapeutic beauty contest.

B D Cheson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346799     DOI: 10.1200/JCO.1992.10.3.352

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology.

Authors:  V Gandhi; L E Robertson; M J Keating; W Plunkett
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 2.  New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.

Authors:  V W Ruiz van Haperen; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15

3.  Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial.

Authors:  L J Kilton; J B Ashenhurst; J L Wade; R L Schilsky; G Shiomoto; R R Blough; S L French; A B Benson
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

4.  Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.

Authors:  A M Burger; J A Double; J Konopa; M C Bibby
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia.

Authors:  Federica Toscanini; Pasqualina De Leo; Giuseppe Calcagno; Federica Malfatti; Alessandro Grasso; Marco Anselmo
Journal:  Case Reports Hepatol       Date:  2011-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.